The Latest in Rheumatoid Arthritis

Meta-Analysis Shows 75% Increased Risk Herpes Zoster With Anti-TNF

July 11, 2012

Rheumatoid Arthritis

Methotrexate Cuts Anti-Adalimumab Antibody Production

July 11, 2012

Rheumatoid Arthritis

FDA Approves REMS for Long-Acting Opioids

July 9, 2012

Early Data Find No Adalimumab Teratogenicity

July 9, 2012

Rheumatoid Arthritis

2010 RA-Classification Criteria Outperform 1987 Criteria

July 6, 2012

Rheumatoid Arthritis

Delaying Adalimumab Tx Impairs Long-Term Response

July 6, 2012

Rheumatoid Arthritis

New Biomarkers Identify Tocilizumab Responders Super Early

July 3, 2012

Rheumatoid Arthritis

Psoriatic Arthritis Screening Tests Deemed Inadequate

June 29, 2012

Rheumatoid Arthritis

FDA Panel Considers Metal-on-Metal Hip Replacements

June 29, 2012

VTE Risk Pumped Up in Rheumatoid Arthritis

June 29, 2012

Rheumatoid Arthritis

Tocilizumab Beats Adalimumab in Monotherapy RA Trial

June 27, 2012

Rheumatoid Arthritis

High Interferon Response, Low B Cells Presage Rheumatoid Arthritis

June 27, 2012

Rheumatoid Arthritis

Synovitis in RA Identifies High Progression Risk

June 26, 2012

Rheumatoid Arthritis

New JAK Inhibitors Show RA Safety, Efficacy

June 25, 2012

Rheumatoid Arthritis

Small Study: Reduced Anti-TNF Dose Still Effective

June 25, 2012

Rheumatoid Arthritis